(Q41401735)

30 September 2017

1 reference

title

Target concentration strategy for cyclosporin monitoring (English)

1 reference

30 September 2017

Morris RG

1

1 reference

30 September 2017

1 March 1997

1 reference

Clinical Pharmacokinetics

30 September 2017

1 reference

30 September 2017

32

1 reference

30 September 2017

3

1 reference

30 September 2017

175-179

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199732030-00001

30 September 2017

0 references

cites work

Survey of cyclosporine therapeutic ranges, assay methodology, and use of 'sparing agents' in Australasian transplant centers

1 reference

12 December 2020

Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine

1 reference

12 December 2020

Methodological and clinical aspects of cyclosporin monitoring: report of the Association of Clinical Biochemists task force

1 reference

12 December 2020

Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin

1 reference

12 December 2020

Theophylline target concentration in severe airways obstruction - 10 or 20 mg/L? A randomised concentration-controlled trial

1 reference

12 December 2020

Specific enzyme-multiplied immunoassay and fluorescence polarization immunoassay for cyclosporin compared with Cyclotrac [125I]radioimmunoassay

1 reference

12 December 2020

Canadian Consensus Meeting on cyclosporine monitoring: report of the consensus panel.

1 reference

12 December 2020

The use of therapeutic drug monitoring to optimise immunosuppressive therapy

1 reference

12 December 2020

Cyclosporin A monitoring in Australia: consensus recommendations

1 reference

12 December 2020

Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel.

1 reference

12 December 2020

Comparison of cyclosporine measurement in whole blood by high-performance liquid chromatography, monoclonal fluorescence polarization immunoassay, and monoclonal enzyme-multiplied immunoassay

1 reference

12 December 2020

Australian cyclosporin therapeutic monitoring method survey: 1993.

1 reference

12 December 2020

DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY.

1 reference

12 December 2020

Concentration-controlled trials. What does the future hold?

1 reference

12 December 2020

Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring

1 reference

12 December 2020

The target concentration approach to clinical drug development.

1 reference

12 December 2020

10.2165/00003088-199732030-00001

Identifiers

DOI

1 reference

PubMed ID

9084957

Dimensions Publication ID

30 September 2017

0 references

1 reference

PubMed ID

9084957